Jeffrey W. Mittleman

Jeffrey W. Mittleman

Holland & Knight LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Massachusetts Legislature Advances Bill to Impose Caps on Drug Prices

The Joint Committee on Health Care Financing of the Massachusetts legislature took up Bill S. 1048, an "Act to promote transparency and cost control of pharmaceutical drug prices," on Sept. 14, 2015. The bill initially was...more

9/22/2015 - Disclosure Requirements Drug Pricing Healthcare Prescription Drugs Public Records

CMS Proposes Changes to 2016 Star Rating Calculations - Medicare Advantage and Medicare Part D Prescription Drug Plans May Be...

The Centers for Medicare and Medicaid Services (CMS or the Agency) released a memorandum requesting comments regarding proposed changes to the 2016 star ratings systems for Medicare Advantage Plans (MA Plans) and Medicare...more

12/11/2014 - CMS Comment Period Health Insurance Medicare Medicare Part D

CMS Announces Final Regulatory Changes to Medicare Advantage and Part D

- CMS issues final Medicare Advantage and Part D regulatory changes after a controversial proposed rule was announced earlier this year. - New requirements for the reporting and return of Medicare Advantage and Part D...more

6/5/2014 - CMS Final Rules Healthcare Medicare Medicare Advantage Medicare Part D Overpayment Pharmaceutical Industry Pharmacies Prescription Drugs

CMS Issues Medicare Advantage And Part D Final Call Letter For 2015

The Medicare Advantage and Part D Final Call Letter announces requirements for the 2015 contract year, including changes to Part C and Part D star ratings and how CMS will evaluate Part D plan structures submitted for the...more

4/16/2014 - CMS Healthcare Medicare Medicare Advantage Medicare Part D

CMS Issues Final Rule on Medical Loss Ratio for Medicare Advantage and Part D

On May 23, 2013, CMS issued its Final Rule on Medical Loss Ratio (MLR) requirements for Medicare Advantage (MA) and Medicare Part D programs. MLR calculates the percentage of revenue used by MA organizations and Part D...more

6/12/2013 - CMS Medical Loss Ratio Medicare Medicare Advantage Medicare Part D Penalties

Massachusetts Public Health Council Approves Regulations Implementing Relaxation of Strict Ban on Gifts from Pharmaceutical and...

On November 21, 2012, the Massachusetts Public Health Council (PHC) approved the final regulatory amendments implementing the Pharmaceutical and Medical Device Manufacturer Conduct Law, MGL ch. 111N, which was amended by Gov....more

12/3/2012 - Medical Devices Pharmaceutical Industry Physician Gift-Ban Law Sunshine Act

Massachusetts Board of Pharmacy Enacts Emergency Regulations Targeting Compounding Activities and Impacting All Registered and...

The Massachusetts Board of Pharmacy (BOP) enacted emergency regulations effective November 1, 2012, in response to the deadly fungal meningitis outbreak caused by drug contamination at a Massachusetts compounding pharmacy....more

11/6/2012 - Meningitis Pharmaceutical Industry Pharmacies

Massachusetts Relaxes Strict Ban on Gifts from Pharmaceutical and Medical Device Manufacturers to Physicians

Governor Deval Patrick signed into law Massachusetts’ fiscal year 2013 budget on July 8, 2012. The budget includes amendments to the state’s Pharmaceutical and Medical Device Manufacturer Conduct Law, MGL ch. 111N. The...more

7/12/2012 - Manufacturers Medical Devices Pharmaceutical Industry Physician Gift-Ban Law Physicians Reporting Requirements

8 Results
|
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×